Bicocca Open Archive

Logo unimib boa

Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Locatelli, V., et al. (2022). Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis. Intervento presentato a: III Edition MORE THAN NEURONS Changing the paradigm for novel therapeutic avenues - 15-17 DECEMBER 2022, Torino, Italia.

Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis

Ramona Meanti
Primo
;Laura Rizzi;Elena Bresciani;Martina Licata;Laura Molteni;Vittorio Locatelli;Antonio Torsello
2022
abstract + poster
GHS, ALS, neuroprotection, neurodegeneration, neuroscience
English
III Edition MORE THAN NEURONS Changing the paradigm for novel therapeutic avenues - 15-17 DECEMBER 2022
2022
2022
https://www.morethanneurons.com/program/
open
Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Locatelli, V., et al. (2022). Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis. Intervento presentato a: III Edition MORE THAN NEURONS Changing the paradigm for novel therapeutic avenues - 15-17 DECEMBER 2022, Torino, Italia.
02 - Intervento a convegno
File in questo prodotto:
File Dimensione Formato  
Meanti-2022-MTN-AAM.pdf

accesso aperto

Descrizione: Intervento a convegno - abstract
Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Licenza: Altro
Dimensione 9.69 kB
Formato Adobe PDF
Visualizza/Apri
9.69 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/521860
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact